Press Releases about AbbVie
AbbVie Inc. (ABBV) Climbs to Annual-High Share Price
March 15, 2022
AbbVie Inc. (ABBV) Climbs to Annual-High Share Price
March 15, 2022
AbbVie Inc. (ABBV): The Winning Streak Continues
February 15, 2022
AbbVie Inc. (ABBV): The Winning Streak Continues
February 15, 2022
From AEG
Via Business Wire
AbbVie Inc. (ABBV) Climbs to Annual-High Share Price
February 04, 2022
AbbVie Inc. (ABBV) Climbs to Annual-High Share Price
February 04, 2022
Watch for Continued Gains in Shares of AbbVie Inc. (ABBV)
February 02, 2022
Global Alzheimer’s Disease Therapeutics Market Projected To Generate Revenue Of $9.97 Billion By 2028
January 04, 2022
Exposures
COVID-19
Watch for Continued Gains in Shares of AbbVie Inc. (ABBV)
December 16, 2021
Is This The Most Exciting Medical Breakthrough Of The Decade
October 19, 2021
Here’s Why SANUWAVE Could Be Worth Double The $550 Million AbbVie Paid For Soliton, Inc.
May 14, 2021
Via AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.